Targeting aggressive B-cell lymphomas through pharmacological activation of the mitochondrial protease OMA1

By sjmartinez • August 30, 2023

Schwarzer A, Oliveira M, Kleppa MJ, Slattery SD, Anantha A, Cooper A, Hannink M, Schambach A, Doerrie A, Kotylarov A, Gaestel M, Hembrough T, Levine J, Luther M, Stocum M, Stiles L, Weinstock DM, Liesa M, Kostura MJ. Targeting aggressive B-cell lymphomas through pharmacological activation of the mitochondrial protease OMA1. Mol Cancer Ther. 2023 Aug 30. doi: 10.1158/1535-7163.MCT-22-0718. Epub ahead of print. PMID: 37643767.

Tags: Endocrinology, Publications

Evaluation of SLC6A8 Species Conservation and the Effect of Pathogenic Variants on Creatine Transport

Diep T, Lipshutz GS. Evaluation of SLC6A8 Species Conservation and the Effect of Pathogenic Variants on Creatine Transport. HGG Adv. 2025 Aug 7:100489. doi: 10.1016/j.xhgg.2025.100489.[...]

Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency

Nasseri Moghaddam Z, Reinhardt EK, Thurm A, Potter BK, Smith M, Graham C, Tiller BH, Baker SA, Bilder DA, Bogar R, Britz J, Cafferty R,[...]

The protein deacetylase SIRT2 exerts metabolic control over adaptive Beta cell proliferation

Wortham M, Ramms B, Zeng C, Benthuysen JR, Sai S, Pollow DP, Liu F, Schlichting M, Harrington AR, Liu B, Prakash TP, Pirie EC, Zhu[...]